Effect of GnRH analogues on apoptosis and release of interleukin-1 and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis
article
OA: bronze
CC0
⤵ 45 in-corpus citations
AI-generated summary
GnRH agonists increased apoptosis and decreased IL-1beta and VEGF release in endometrial cell cultures from endometriosis patients and controls, effects reversed by a GnRH antagonist.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: The aim of the present study was to evaluate the effect of GnRH analogues on the in-vitro eutopic endometrial cell apoptosis and release of interleukin-1beta (IL-1beta) and vascular endothelial growth factor (VEGF). METHODS: Biopsy specimens of eutopic endometrium obtained from 16 women with untreated endometriosis and 14 controls were studied. Apoptosis, IL-1beta and VEGF release were evaluated in epithelial endometrial cell cultures after incubation with leuprolide acetate (LA) as GnRH agonist, antide as GnRH antagonist, and a combination of both. The percentage of apoptotic cells was evaluated by the acridine orange-ethidium bromide technique, and IL-1beta and VEGF concentrations were assessed by using commercial enzyme-linked immunosorbent assay (ELISA) kits. RESULTS: We found that LA (100 ng/ml) enhanced apoptosis in endometrial cell cultures from endometriosis patients and controls and this effect was reversed by antide at 10(-7) mol/l. IL-1beta and VEGF release was downregulated by LA in cultures from controls and endometriosis patients. The addition of antide 10(-7) mol/l reversed this inhibition. Endometrial cultures treated with antide at 10(-7) mol/l did not show any significant effects compared with basal conditions. CONCLUSIONS: GnRH agonists appear to have a direct effect in endometrial cells cultures, by enhancing the percentage of apoptotic cells and decreasing the release of pro-mitogenic cytokines such as IL-1beta and VEGF.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (34)
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
- Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis via openalex
- Effect of Peritoneal Fluid From Endometriosis Patients on Endometrial Stromal Cell Proliferation In Vitro via openalex
- Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate via openalex
- Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis via openalex
- Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro via openalex
- Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1 via openalex
- Interleukin 1β, interleukin-6, and tumor necrosis factor-α in endometriotic tissue and in endometrium via openalex
- Leuprorelin via openalex
- Oral contraceptives treatment suppresses proliferation and enhances apoptosis of eutopic endometrial tissue from patients with endometriosis. via openalex
- Peritoneal Cellular Immunity and Endometriosis via openalex
- Regulation of angiogenesis in the endometrium via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Vascular endothelial growth factor and endometriotic angiogenesis via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- W2173390200 via openalex
- W2275699845 via openalex
- W2411029809 via openalex
- W72110172 via openalex
- W3216072532 via openalex
- W1978468923 via openalex
- W1994088961 via openalex
- W2017967258 via openalex
- W2043773563 via openalex
- W2063559455 via openalex
- W2076960363 via openalex
- W2093303434 via openalex
- W2117842006 via openalex
- W2140246703 via openalex
- W2141046053 via openalex
- W2142285406 via openalex
- W2143157162 via openalex
- W2159137057 via openalex
- W2171275402 via openalex
Cited by (45)
- Emerging signal transduction pathways and the role of bacterial extracellular vesicles linked to the pathogenesis of endometriosis 2026
- Bioinformatics analysis for identifying hub genes in endometriosis and recurrent implantation failure: molecular pathways to enhanced IVF success 2025
- Safety of current strategies to manage moderate to severe pain in patients with endometriosis 2025
- The effect of GnRH-a on the angiogenesis of endometriosis 2024
- Efficacy of long-term pituitary down-regulation pretreatment prior to in vitro fertilization in infertile patients with endometriosis: A meta-analysis 2023
- The role of the junctional zone in the management of adenomyosis with infertility 2023
- Levels of oxidative stress and apoptosis-related biomarkers in endometriosis 2023
- Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment? 2023
- The Role of the Microenvironment in Endometriosis: Parallels and Distinctions to Cancer 2022
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
- Effect of<scp>epigallocatechin‐3‐gallate</scp>on the status of<scp>DNA</scp>methylation of E‐cadherin promoter region on endometriosis mouse 2020
- Suppressive Effects of Ursolic Acid on Human Endometriotic Stromal Cells Survival 2019
- Effect of Prolonged GnRH Agonist Downregulation on ICSI Outcome in Patients With Endometriomas of Less Than 5 cm: A Randomized Controlled Trial 2018
- PENGARUH PEMBERIAN GENISTEIN TERHADAP PENURUNAN KADAR TNF ALPHA PADA ZALIR PERITONEAL MENCIT MODEL ENDOMETRIOSIS 2018
- Apoptosis induction of human endometriotic epithelial and stromal cells by noscapine. 2016
- Gonadotrophin‐releasing hormone analogue or dienogest plus estradiol valerate to prevent pain recurrence after laparoscopic surgery for endometriosis: a multi‐center randomized trial 2015
- Analogs of Luteinizing Hormone-Releasing Hormone in the Treatment of Endometriosis 2015
- Therapeutic Options for Management of Endometrial Hyperplasia: An Update 2015
- Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment? 2014
- A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model 2014
- GnRH agonists induce endometrial epithelial cell apoptosis via GRP78 down-regulation 2014
- The effects of genistein as antiinflammatory and antiangiogenesis in primary endometriosis cell culture 2014
- Regression of experimental endometriotic implants in a rat model with the angiotensin <scp>II</scp> receptor blocker losartan 2014
- Study of ultrastructure and apoptosis in the endometrium of women with or without endometriosis. 2013
- Effect of DMPA on IL-1 Alpha in Serum of Women with Endometrioma 2013
- Evaluation of selected angiogenic and inflammatory markers in endometriosis before and after danazol treatment 2013
- Effect of GnRH-II on the ESC proliferation, apoptosis and VEGF secretion in patients with endometriosis in vitro. 2013
- Natural therapies assessment for the treatment of endometriosis 2012
- Somatostatin and somatostatin analogues reduce PDGF-induced endometrial cell proliferation and motility 2012
- Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show? 2010
- Effect of vascular endothelial growth factor and interleukin-1β on apoptosis in endometrial cell cultures from patients with endometriosis and controls 2010
- Apoptosis and endometriosis 2010
- Regulação da resposta imune e endometriose 2008
- Treatment strategies for endometriosis 2008
- The Role of GnRH Analogues in Endometriosis-Associated Apoptosis and Angiogenesis 2008
- The levonorgestrel-releasing intrauterine system and endometriosis staging 2007
- GnRH analogs: Options for endometriosis-associated pain treatment 2006
- The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis 2006
- Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs 2006
- GnRH II as a possible cytostatic regulator in the development of endometriosis 2005
- Concentrations of interleukin (IL)-1α, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis 2005
- The role of immunology in the etiopathogenesis, diagnosis and treatment of endometriosis O papel da imunologia na etiopatogenia, diagnóstico e tratamento da endometriose 2005
- Angiogenese und antiangiogene Therapien der Endometriose 2004
- Apoptosis in human endometrium and endometriosis 2004
- Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: an overview 2004
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:12:50.257867+00:00
License: CC0
· commercial use OK